In the past decade, the use of opioids for chronic pain has increased at an alarming rate. High rates of opioid prescribing have been accompanied by a concomitant increase in opioid use disorders as well as opioid overdoses. Opioid use disorder is associated with decreased health-related quality of life and increased risk of death. Both the physician-facing Clinical Decision Support (CDS) and patient-facing Patient Education and Activation Tools (PEATs) are widely used evidence-based interventions to mitigate the risk of opioid use disorder, but they have never been tested in a head-to-head comparative effectiveness trial.
